Edward Stolarski, MD
Adult Reconstructive Orthopaedic Surgery · Sarasota, FLNPI 1164461406
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (56.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Medacta USA, Inc. at 59.0% of the total. Reporting peaked in 2024 at $172,696 and has fallen 85.2% since, to $25,590 in 2025. Among adult reconstructive orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 189 payments — averaging $2353.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$262K
- Canary Medical USA LLC$151K
- Zimmer Biomet$28K
- Corentec America Inc$2K
- Stryker$890
- Nextstep Arthropedix, LLC$748
- plus $1K from 14 others
Across 192 payments — averaging $12,081 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$1.1M
- Pfizer$460K
- Pacira Therapeutics, Inc.$303K
- Biotissue Holdings Inc.$271K
- Canary Medical USA LLC$84K
- Regeneron$29K
- plus $84K from 6 others
What the payments were for
- Royalty or licence$249,24656%
- Consulting fees$184,93842%
- Travel & lodging$4,7691%
- Food & beverage$5,7351%
- Other$370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 72 | $262,186 |
| Canary Medical USA LLC | 2 | $150,527 |
| Zimmer Biomet | 65 | $27,517 |
| Corentec America Inc | 1 | $1,500 |
| Stryker(2 entities) | 17 | $890 |
| Nextstep Arthropedix, LLC | 2 | $748 |
| Smith+Nephew | 5 | $348 |
| Heraeus Medical, LLC. | 7 | $240 |
| Pacira Therapeutics, Inc. | 2 | $193 |
| Biocomposites Inc | 1 | $144 |
| Baxter Healthcare | 3 | $118 |
| Next Science LLC | 1 | $114 |
| Relievant Medsystems, Inc. | 1 | $57 |
| Microport Orthopedics Inc | 2 | $42 |
| Boston Scientific | 1 | $23 |
| Amgen | 1 | $22 |
| Coastal Medical Technologies LLC | 1 | $22 |
| Fidia Pharma USA Inc. | 3 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $12 |
| Ossur Americas, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MASTERLOC$152,436
- M-VIZION$78,795
- M-Vizion Femoral Revision System$21,162
- Avenir$11,625
- ROSA-Knee$9,151
- G7$6,936
- ROSA$2,607
- AMISTEM$2,140
- Bencox Hip System$1,500
- LOSPA Knee System$1,500
- Persona$1,477
- Taperloc$1,200
- Arcos$1,200
- iNSitu Hip System$748
- QUADRA$700
- GMK SPHERE$368
- ACCOLADE$288
- Zilretta$170
- Stimulan$144
- mymobility Platform$138
How this compares
$444,726 in reported general payments places this provider in the 90th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.
See all adult reconstructive orthopaedic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 149 | $2,818 |
| Amoxicillin | 593 | $1,015 |
| Clindamycin Hcl | 113 | $345 |
| Meloxicam | 118 | $333 |
| Methylprednisolone | 51 | $283 |
| Cephalexin | 33 | $203 |
| Ondansetron Hcl | 20 | $121 |
| Mupirocin | 16 | $103 |
| Azithromycin | 14 | $77 |
| Ciprofloxacin Hcl | 24 | $75 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $28 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Sarasota
- John ThomasSarasota$12K
- Sean DingleSarasota$8K
- Carlos LaverniaMiami$5.4M
- Juan SuarezMiami$3.9M
- John RedmondJacksonville$987K
- Gavan DuffyJacksonville$543K
- Timothy van de LeurSummerfield$511K
- Andrew NoblePalm Beach Gardens$308K
- Raul GostheMiami$252K
- Chancellor GrayGainesville$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.